ARTICLE | Clinical News
ALX1-11: Began Phase I trial
April 18, 1994 7:00 AM UTC
Allelix Biopharmaceuticals Inc. (TSE:AXB), Toronto Product: ALX1-11, parathyroid hormone Indication: Osteoporosis Status: Began a two-arm European Phase I trial of the drug, which is being co-develo...